Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Vaxcyte, Inc. (PCVX) had Free Cash Flow per Share of $-1.27 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-140.72M |
|
-- |
|
-- |
|
$180.79M |
|
$-180.79M |
|
$40.08M |
|
$-140.72M |
|
$-140.72M |
|
$-140.72M |
|
$-140.72M |
|
$-140.72M |
|
$-140.72M |
|
$-180.79M |
|
$-180.83M |
|
135.69M |
|
135.69M |
|
$-1.04 |
|
$-1.04 |
|
| Balance Sheet Financials | |
$1.72B |
|
$217.16M |
|
$1.66B |
|
$3.38B |
|
$97.00M |
|
-- |
|
$81.08M |
|
$178.08M |
|
$3.20B |
|
$3.20B |
|
$3.20B |
|
128.94M |
|
| Cash Flow Statement Financials | |
$-166.27M |
|
$123.32M |
|
$0.76M |
|
$389.19M |
|
$348.17M |
|
$-41.03M |
|
$30.61M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
17.70 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-171.70M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-4.40% |
|
-4.40% |
|
-4.17% |
|
-4.40% |
|
$24.82 |
|
|
Free Cash Flow per Share |
$-1.27 |
$-1.23 |
|